共 12 条
- [1] Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (05): : 341 - 353
- [3] Anti-TNF α antibodies in patients with inflammatory bowel disease naive to anti-TNF therapy treated with biosimilar infliximab (CT-P13): a prospective single-centre real-life study [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S396 - S397
- [6] Usefulness of monocytosis as biomarker to predict relapse in inflammatory bowel disease patients in remission under maintenance treatment with anti-TNF drugs: A prospective longitudinal cohort study [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S213 - S214
- [7] Clinical outcomes of vedolizumab maintenance treatment for Korean patients with inflammatory bowel disease who failed anti-TNF therapy: A KASID prospective multicenter cohort study [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S523 - S524
- [8] Increased Prevalence of Human Polyomavirus JC Viruria in Chronic Inflammatory Rheumatic Diseases Patients in Treatment with Anti-TNF α: A 18 Month Follow-Up Study [J]. FRONTIERS IN MICROBIOLOGY, 2016, 7
- [9] Usefulness of consecutive faecal calprotectin measurements to predict relapse in inflammatory bowel disease patients under maintenance treatment with anti-TNF therapy: a prospective longitudinal cohort study [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S147 - S147